Background/Aims The inflammatory bowel diseases (IBD), ulcerative colitis (UC), and Crohn’s disease (CD) are chronic diseases mostly affecting young patients. As they are diseases accompanying patients for their entire life, and the quality of life (QUOL) interacts with disease activity, improving QUOL should be one of the main goals of therapy. This study aims to identify factors contributing to good or impaired QUOL.
Methods Questionnaires addressing health-related QUOL and other psychological and social features were positioned on our institutions’ webpage and on the webpage of the largest self-help group for IBD in Germany. Patients were subdivided according to their QUOL score with a cutoff of <60. We used the Short Inflammatory Bowel Disease Questionnaire, the Assessment of the Demand for Additional Psychological Treatment, and the Fear of Progression Questionnaire Short Form.
Results High numbers of patients in both subgroups showed an impaired QUOL (87.34% in UC, 91.08% in CD). Active extraintestinal manifestations, smoking, high fear of progression and high demand for psychotherapy were associated with reduced QUOL. In addition, polypharmacological interventions did not result in a good QUOL, but ostomies are linked to improved QUOL especially in CD patients.
Conclusions Scores used in clinical day-to-day-practice mainly focusing on somatic factors do not sufficiently address important aspects concerning QUOL. Most importantly, extraintestinal manifestations show a hitherto underestimated impact on QUOL.
Citations
Citations to this article as recorded by
Self-perception and adjustment to Crohn's disease in emerging and young adults: The clinical and psychosocial associated factors Nathalie Touma, Carolina Baeza-Velasco Pratiques Psychologiques.2025; 31(1): 41. CrossRef
Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialists Olga Maria Nardone, Giulio Calabrese, Alessia La Mantia, Guido Daniele Villani, Matteo Megna, Sara Cacciapuoti, Francesca Foglia, Rosario Peluso, Ermelinda D’Alessandro, Mario Ferrante, Anna Testa, Alessia Dalila Guarino, Antonio Rispo, Fabiana Castiglion Therapeutic Advances in Gastroenterology.2025;[Epub] CrossRef
Evolution of Extraintestinal Manifestations in Patients With Ulcerative Colitis Post-Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis: A Single-Center Retrospective Study Alex Barenboim, Tali Epstein Weiss, Orestis Argyriou, Nathaniel Aviv Cohen, Yehuda Kariv, Meir Zemel, Eran Itzkowitz, Ron Greenberg, Noam Goder, Sara Borok, Kapil Sahnan, Hagit Tulchinsky, Nitsan Maharshak Inflammatory Bowel Diseases.2025;[Epub] CrossRef
Beyond the Gut: A Systematic Review and Meta-analysis of Advanced Therapies for Inflammatory Bowel Disease-associated Extraintestinal Manifestations Ágnes Eszter Tímár, Andrea Párniczky, Kinga Anna Budai, Márk Viktor Hernádfői, Emese Kasznár, Péter Varga, Péter Hegyi, Szilárd Váncsa, Réka Tóth, Dániel Sándor Veres, Miklós Garami, Katalin Eszter Müller Journal of Crohn's and Colitis.2024; 18(6): 851. CrossRef
The association between fear of progression and medical coping strategies among people living with HIV: a cross-sectional study Bing Li, Xiaoli Lin, Suling Chen, Zhe Qian, Houji Wu, Guichan Liao, Hongjie Chen, Zixin Kang, Jie Peng, Guangyu Liang BMC Public Health.2024;[Epub] CrossRef
Relationship between fear of progression and quality of life in inflammatory bowel disease: Mediating role of health literacy and self‐care Xin Hu, Liyuan Xu Journal of Advanced Nursing.2024; 80(10): 4147. CrossRef
Risk Factors of Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study Jiyoung Yoon, Seung Wook Hong, Kyung-Do Han, Seung-Woo Lee, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Joo Sung Kim, Hyuk Yoon Gut and Liver.2024; 18(3): 489. CrossRef
Nutritional Profile, Disease Severity, and Quality of Life of Patients with Inflammatory Bowel Disease: A Case–Control Study Lea N. Sayegh, Firas Haddad, Layane Bou Jaoude, Nicole Fakhoury-Sayegh, Gessica N. H. A. Heraoui, Zainab Nasrallah, Charbel Chidiac, Rashad Nawfal, Fadi F. Francis, Fadi H. Mourad, Jana G. Hashash Nutrients.2024; 16(12): 1826. CrossRef
Development and Assessment of a Novel Ulcerative Colitis–Specific Quality of Life Questionnaire: A Prospective, Multi-Institutional Study Jihye Park, Hyun-Soo Zhang, Chung Mo Nam, Joo Sung Kim, Young-Ho Kim, Dong Il Park, Byong Duk Ye, Yoon Tae Jeen, Sehyun Kim, Jae Hee Cheon Yonsei Medical Journal.2024; 65(11): 636. CrossRef
Comprehensive analysis of psychological symptoms and quality of life in early patients with IBD: a multicenter study from China Yupei Liu, Jiaming Hu, Shan Tian, Jixiang Zhang, Ping An, Yanrui Wu, Zhongchun Liu, Changqing Jiang, Jie Shi, Kaichun Wu, Weiguo Dong BMC Psychiatry.2024;[Epub] CrossRef
Evaluation of the Effect of Probiotic Supplementation on Intestinal Barrier Integrity and Epithelial Damage in Colitis Disease: A Systematic Review Dilek Sivri, Betül Şeref, Melike Şare Bulut, Makbule Gezmen Karadağ Nutrition Reviews.2024;[Epub] CrossRef
Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls Min Heo, Young Soo Park, Hyuk Yoon, Nam-Eun Kim, Kangjin Kim, Cheol Min Shin, Nayoung Kim, Dong Ho Lee Gut and Liver.2023; 17(1): 108. CrossRef
Obesity and novel management of inflammatory bowel disease Jee Hyun Kim, Chang-Myung Oh, Jun Hwan Yoo World Journal of Gastroenterology.2023; 29(12): 1779. CrossRef
A Holistic Perspective on How Photobiomodulation May Influence Fatigue, Pain, and Depression in Inflammatory Bowel Disease: Beyond Molecular Mechanisms E-Liisa Laakso, Tatjana Ewais Biomedicines.2023; 11(5): 1497. CrossRef
Psychoemotional disorders of patients with inflammatory bowel diseases: prevalence, pathogenesis and treatment options Igor G. Bakulin, Venera Sh. Stamboltsyan, Inna A. Oganezova Russian Family Doctor.2023; 27(2): 23. CrossRef
CE: Nursing Care for Patients After Ostomy Surgery Heidi H. Cross AJN, American Journal of Nursing.2023; 123(8): 34. CrossRef
Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN) Jae Hee Cheon, Hyun-Soo Kim, Dong Soo Han, Sung Kook Kim, Sung Jae Shin, Joo Sung Kim, Byong Duk Ye, Geun Am Song, YoungJa Lee, Youngdoe Kim, Yoosun Lee, Won Ho Kim Gut and Liver.2023; 17(5): 777. CrossRef
Validity and reliability of the Indonesian version of the 9-item Inflammatory Bowel Disease Questionnaire (IBDQ-9) Dekta Filantropi Esa, Hamzah Shatri, Cleopas Martin Rumende, Adityo Susilo, Hasan Maulahela, Achmad Fauzi, Marcellus Simadibrata Medical Journal of Indonesia.2023; 32(3): 168. CrossRef
Prediction of Clinical Remission with Adalimumab Therapy in Patients with Ulcerative Colitis by Fourier Transform–Infrared Spectroscopy Coupled with Machine Learning Algorithms Seok-Young Kim, Seung Yong Shin, Maham Saeed, Ji Eun Ryu, Jung-Seop Kim, Junyoung Ahn, Youngmi Jung, Jung Min Moon, Chang Hwan Choi, Hyung-Kyoon Choi Metabolites.2023; 14(1): 2. CrossRef
Apex Score: Predicting Flares in Small-Bowel Crohn’s Disease After Mucosal Healing Vítor Macedo Silva, Marta Freitas, Pedro Boal Carvalho, Francisca Dias de Castro, Tiago Cúrdia Gonçalves, Bruno Rosa, Maria João Moreira, José Cotter Digestive Diseases and Sciences.2022; 67(4): 1278. CrossRef
Study on the impact of sexually transmitted infections on Quality of Life, mood and sexual function Giulia CICCARESE, Francesco DRAGO, Francesco COPELLO, Giorgia BODINI, Alfredo REBORA, Aurora PARODI Italian Journal of Dermatology and Venereology.2022;[Epub] CrossRef
Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis Nagesh Kamat, Sudheer K Vuyyuru, Saurabh Kedia, Pabitra Sahu, Bhaskar Kante, Peeyush Kumar, Mukesh Kumar Ranjan, Mukesh Kumar Singh, Sambuddha Kumar, Vikas Sachdev, Govind Makharia, Vineet Ahuja Intestinal Research.2022; 20(2): 269. CrossRef
An overview of ozanimod as a therapeutic option for adults with moderate-to-severe active ulcerative colitis Catherine Rowan, Ryan Ungaro, Saurabh Mehandru, Jean-Frederic Colombel Expert Opinion on Pharmacotherapy.2022; 23(8): 893. CrossRef
Psychological Effects and Medication Adherence among Korean Patients with Inflammatory Bowel Disease during the Coronavirus Disease 2019 Pandemic: A Single-Center Survey Ji Eun Ryu, Sung-Goo Kang, Sung Hoon Jung, Shin Hee Lee, Sang-Bum Kang Journal of Clinical Medicine.2022; 11(11): 3034. CrossRef
The future of telemedicine and wearable technology in IBD Catherine Rowan, Robert Hirten Current Opinion in Gastroenterology.2022; 38(4): 373. CrossRef
Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education Seulji Kim, Seong-Joon Koh Intestinal Research.2022; 20(4): 389. CrossRef
The Clinical Features of Inflammatory Bowel Disease in Patients with Obesity Seong Kyun Kim, Ho-Su Lee, Beom-Jun Kim, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park, Masanao Nakamura Canadian Journal of Gastroenterology and Hepatology.2021; 2021: 1. CrossRef
Lesson from Real-World Experience: Optimal Treatment with Anti-Tumor Necrosis Factor for Ulcerative Colitis Jaeyoung Chun Gut and Liver.2021; 15(6): 793. CrossRef
Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease Jose María Huguet, Xavier Cortés, Marta Maia Bosca-Watts, Marian Aguas, Nuria Maroto, Lidia Martí, Cirilo Amorós, Jose María Paredes World Journal of Clinical Cases.2021; 9(36): 11285. CrossRef
The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study Tiziana Larussa, Danilo Flauti, Ludovico Abenavoli, Luigi Boccuto, Evelina Suraci, Raffaella Marasco, Maria Imeneo, Francesco Luzza Journal of Clinical Medicine.2020; 9(8): 2416. CrossRef